Search research articles
Contact Us
Filters
Showing results (111-120 of 492) with videos related to
Page
of 50
Sort By:
European Urology
|
April 9, 2023
Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022
Michael J Morris, Oliver Sartor, Johann S de Bono, et al.
Bone Marrow Transplantation
|
November 3, 2015
Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant
B Pillay, S J Lee, L Katona, et al.
European Urology Focus
|
June 25, 2021
Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications
Beshara Sheehan, Christina Guo, Antje Neeb, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugs
C P Carden, U Banerji, S B Kaye, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 12, 2017
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
S Lheureux, C Denoyelle, P S Ohashi, et al.
British Journal of Cancer
|
September 20, 2006
Improving the outcome of patients with castration-resistant prostate cancer through rational drug development
G Attard, D Sarker, A Reid, et al.
Cancers
|
November 3, 2018
Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles
Afroditi Nanou, Mateus Crespo, Penny Flohr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2015
CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer
Niven Mehra, Zafeiris Zafeiriou, David Lorente, et al.
European Urology
|
August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate Cancer
Adam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Experimental Hematology
|
January 21, 2000
Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages
D I Jarmin, R J Nibbs, T Jamieson, et al.
Page
of 50
Search research articles
Search
Showing results (111-120 of 492) with videos related to
Sort By:
Page
of 50
European Urology
|
April 9, 2023
Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022
Michael J Morris, Oliver Sartor, Johann S de Bono, et al.
Bone Marrow Transplantation
|
November 3, 2015
Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant
B Pillay, S J Lee, L Katona, et al.
European Urology Focus
|
June 25, 2021
Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications
Beshara Sheehan, Christina Guo, Antje Neeb, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugs
C P Carden, U Banerji, S B Kaye, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 12, 2017
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
S Lheureux, C Denoyelle, P S Ohashi, et al.
British Journal of Cancer
|
September 20, 2006
Improving the outcome of patients with castration-resistant prostate cancer through rational drug development
G Attard, D Sarker, A Reid, et al.
Cancers
|
November 3, 2018
Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles
Afroditi Nanou, Mateus Crespo, Penny Flohr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2015
CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer
Niven Mehra, Zafeiris Zafeiriou, David Lorente, et al.
European Urology
|
August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate Cancer
Adam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Experimental Hematology
|
January 21, 2000
Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages
D I Jarmin, R J Nibbs, T Jamieson, et al.
Page
of 50